Antimicrobial Susceptibility Testing Market Worth $5.09 billion by 2027 at a CAGR of 6.1%, Global Opportunity Analysis and Industry Forecast (2019-2027)

Meticulous Research�- leading global market research company published a research report titled "Antimicrobial Susceptibility Testing Market by Product (Manual Testing, Automated AST, Consumable), Method (Disk Diffusion, Dilution), Application (Clinical Diagnosis, Epidemiology), End User (Diagnostic Laboratories, Hospital) - Forecast to 2027".

To get valuable insights into the market, Download sample report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5062

According to this latest publication from Meticulous Research�, the global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% between 2019-2027 to reach to $5.09 billion by 2027. The growth in the overall antimicrobial susceptibility testing market is mainly attributed to the rising global incidences of infectious diseases, increased funding and government initiatives, and emergence of multidrug resistance. However, stringent government regulations are a key factor expected to hinder the adoption of antimicrobial susceptibility testing products over the coming years.

The global antimicrobial susceptibility testing market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027- by product (manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, consumable), method (disk diffusion, rapid automated AST, dilution, and other methods), application (clinical diagnosis, drug discovery & development, and other applications), end user (diagnostic laboratories, hospitals, pharma biotech industry, and research & academic institutes), and geography. The study also evaluates industry competitors and analyzes the market at the regional and country level.

Based on product type, the manual susceptibility testing products segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019; however, automated AST products are expected to register the faster growth during the forecast period. Less time for susceptibility testing than the manual methods, higher accuracy due to minimization of the human interference, and incessant launch of newer automated devices by manufacturers are some of the key factors fueling the growth of the automated AST product market.

Request for a premium sample report @ https://www.meticulousresearch.com/request-sample-report/cp_id=5062

Based on application, the clinical diagnostics segment accounted for the largest share of the overall antimicrobial susceptibility testing market in 2019 and is also expected to register the fastest growth between 2019 and 2027. The factors such as growing awareness about the use of antimicrobial susceptibility testing methods for diagnostic applications, technological advancements in AST products for clinical diagnostic applications, rising burden of infectious diseases with antimicrobial resistance, and positive government intervention regarding early disease screening are driving the growth of this segment.

Geographically, North America commanded the largest share of the global antimicrobial susceptibility testing market in 2019, followed by Europe and Asia Pacific. The factors such as easy accessibility, increasing prevalence of antimicrobial resistance, and better adoption of technologically advanced susceptibility testing methods and products are accelerating the growth of antimicrobial susceptibility testing market in the North American region.

The key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioM�rieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China) among others.

Enquire or share your questions if any @ https://www.meticulousresearch.com/enquire-before-buying/cp_id=5062

Asia-Pacific

Office No-202, 203,204,205,206;
2nd Floor, Pushpak Business Hub,
Wakad, Pimpri-Chinchwad,
411057, India.

Meticulous Research� was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.

This release was published on openPR.